Biotech industry.
FY13 appropriations bills, including issues related to FDA funding and drug approval/review oversight process. Legislation related to altering sequestration targets.  Issues related to comprehensive tax reform, tax treatment of foreign-owned U.S. corporations, and tax extenders, including R & D tax credit.   S.3521, Family and Business Tax Cut Certainty Act of 2012 (tax "extenders").  Corporate tax reform issues. Implementation of healthcare reform law. FDA drug approval and appeal oversight process.  Issues related to patient and physician choice in medical treatments. PDUFA reauthorization.
BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SQUIRE PATTON BOGGS
2550 M STREET, NW, WASHINGTON, DC, 20037, US
KEVIN O'NEILL MANNY ROSSMAN (Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09) KEVIN O'NEILL MANNY ROSSMAN (Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09)
Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09